CLONAZEPAM (PORT. 344/98 – LISTA B1) 2,5 MG/ML SOL OR CT FR GOT VD AMB X 20 ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1256802300018
  • GGREM 528512040116206
  • Código de barras 7899547502251

O que a fonte publica

Detentor do registro
PRATI DONADUZZI & CIA LTDA
Princípios ativos
CLONAZEPAM
Embalagem
2,5 MG/ML SOL OR CT FR GOT VD AMB X 20 ML
Tipo de produto
Genérico
Classe terapêutica
N3A - ANTIEPILÉPTICOS

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:528512040116206
{
  "name": "CLONAZEPAM (PORT. 344/98 – LISTA B1) 2,5 MG/ML SOL OR CT FR GOT VD AMB X 20 ML",
  "holder": "PRATI DONADUZZI & CIA LTDA",
  "stripe": null,
  "barcodes": [
    "7899547502251"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "528512040116206",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "73.856.593/0001-66",
  "priceRegime": "Regulado",
  "productName": "CLONAZEPAM (PORT. 344/98 – LISTA B1)",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "2,5 MG/ML SOL OR CT FR GOT VD AMB X 20 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "11.88",
    "icms-12": "13.50",
    "icms-17": "14.31",
    "icms-18": "14.49",
    "icms-19": "14.67",
    "icms-20": "14.85",
    "icms-21": "15.04",
    "icms-22": "15.23",
    "icms-23": "15.43",
    "icms-17.5": "14.40",
    "icms-19.5": "14.76",
    "icms-20.5": "14.94",
    "icms-22.5": "15.33",
    "icms-12-alc": "13.34",
    "icms-17-alc": "14.14",
    "icms-18-alc": "14.31",
    "icms-19-alc": "14.49",
    "icms-20-alc": "14.67",
    "icms-21-alc": "14.86",
    "icms-22-alc": "15.05",
    "icms-23-alc": "15.24",
    "withoutTaxes": "11.74",
    "icms-17.5-alc": "14.23",
    "icms-19.5-alc": "14.58",
    "icms-20.5-alc": "14.76",
    "icms-22.5-alc": "15.15"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "CLONAZEPAM",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "16.38",
    "icms-12": "18.61",
    "icms-17": "19.72",
    "icms-18": "19.97",
    "icms-19": "20.22",
    "icms-20": "20.47",
    "icms-21": "20.73",
    "icms-22": "20.99",
    "icms-23": "21.27",
    "icms-17.5": "19.85",
    "icms-19.5": "20.35",
    "icms-20.5": "20.59",
    "icms-22.5": "21.13",
    "icms-12-alc": "18.44",
    "icms-17-alc": "19.55",
    "icms-18-alc": "19.78",
    "icms-19-alc": "20.03",
    "icms-20-alc": "20.28",
    "icms-21-alc": "20.54",
    "icms-22-alc": "20.81",
    "icms-23-alc": "21.07",
    "withoutTaxes": "16.23",
    "icms-17.5-alc": "19.67",
    "icms-19.5-alc": "20.16",
    "icms-20.5-alc": "20.40",
    "icms-22.5-alc": "20.94"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "CLONAZEPAM"
  ],
  "therapeuticClass": "N3A - ANTIEPILÉPTICOS",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1256802300018",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "N3A",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:528512040116206"